Medtronic, Inc. (MDT) Gets Two Positive Data Points At ACC - Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Steven Lichtman reiterated an Outperform rating and $104.00 price target on Medtronic, Inc. (NYSE: MDT) after positive data ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
